Annotations: 9MFN

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A [auth H]	NTP_transf_3	e9mfnH01	A: alpha arrays	X: HTH	H: HTH	T: Three-helical HTH	F: NTP_transf_3	ECOD (v295)
B [auth L]	NTP_transf_3	e9mfnL01	A: alpha arrays	X: HTH	H: HTH	T: Three-helical HTH	F: NTP_transf_3	ECOD (v295)

Chain	Chain Class	Chain Subclass	Chain Type	Antigen Name(s)	Provenance Source
A [auth H]	Heavy Chain	IGHV4	-	-	SAbDab (2026-06-26)
B [auth L]	Light Chain	IGKV1	Kappa	-	SAbDab (2026-06-26)

Chain	Name	Target	Provenance Source
A [auth H]	Bafisontamab	EGFR/ERBB1/HER1, MET/HGFR	Therapeutic SAbDab (2026-06-26)
B [auth L]	Demupitamab	EGFR/ERBB1/HER1, MET/HGFR	Therapeutic SAbDab (2026-06-26)

Modified Residue(s)
Chain	Residue(s)	Description
A [auth H]	PCA	Parent Component: GLN : AA0031 : 2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

9MFN | pdb_00009mfn